Clasado Biosciences has appointed Sebastian Nummelin as APAC Regional Director. The move strengthens its commercial presence in the Asia-Pacific market as demand for scientifically validated prebiotic ingredients continues to accelerate.
With almost two decades of experience across the APAC region, Sebastian brings a wealth of expertise in sales, market development and commercial partnerships across the health, nutrition and supplement sectors. His career spans senior roles within the biotics industry, during which he established and grew commercial operations across South-East Asia, China, Japan, Australia and New Zealand and beyond. Sebastian will focus on expanding Clasado’s reach across the region, working closely with formulators and brands.
The appointment comes at a significant moment for the prebiotic category in Asia-Pacific. The region’s prebiotics market is projected to grow at an impressive compound annual growth rate of 12.4% according to Grand View Research, driven by rising consumer awareness of gut health and increasing demand for science-backed functional ingredients. In China, prebiotics are expected to follow a trajectory closely mirroring the country’s probiotics boom, with consumers demonstrating a clear appetite for clinically substantiated health solutions.
Marcelo Durante, VP of Sales and Marketing at Clasado Biosciences, commented: “Sebastian’s track record of building commercial relationships and opening markets across the APAC region is exceptional, and his deep understanding of the supplement and nutrition landscape makes him ideally placed to accelerate our growth in this strategically important part of the world.”
Sebastian added: “It’s a very exciting time to be working in this space. Consumer interest in gut health across Asia-Pacific is growing rapidly, and the industry is innovating at pace to meet that demand.”